Rejuvenate Bio secures $4M to advance gene therapy for a devastating heart disease
BioProcess International - 27-Aug-2024A promising one-time treatment approach for arrhythmogenic cardiomyopathy
Daniel Oliver
Co-Founder and CEO at Rejuvenate Bio.
Specialties: business consulting contract management, corporate finance, grant writing, management, mechanical engineering, mentoring, negotiation, profit, strategic, venture capital,
Visit website: https://www.rejuvenatebio.com/ourteam
See also: 
Rejuvenate Bio
- Company delivering age-reversing gene therapies for animals
Details last updated 13-Feb-2020
Daniel Oliver is also referenced in the following:
Global Healthspan Summit 2023
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
Daniel Oliver News
Rejuvenate Bio partners with animal company to develop gene therapy for canine osteoarthritis
Biospace - 14-Feb-2024Single dose injection targets root causes, offering long-term relief & improved quality of life
Stealthy Harvard startup wants to reverse aging
MIT Technology Review - 09-May-2018Rejuvenate Bio is cofounded by George Church of Harvard Medical School. Will make animals “young...
